Preemption Summary Judgment Granted In Herceptin MDL About Misleading Vial Volume
TULSA, Okla. — The Oklahoma federal judge presiding over the Herceptin multidistrict litigation on March 20 granted summary judgment to defendant Genentech Inc. after finding that the complaints by cancer treatment...To view the full article, register now.
Already a subscriber? Click here to view full article